Literature DB >> 7789635

Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle.

J L Azevedo1, J O Carey, W J Pories, P G Morris, G L Dohm.   

Abstract

Insulin and muscle contraction stimulate glucose transport into muscle cells by separate signaling pathways, and hypoxia has been shown to operate via the contraction signaling pathway. To elucidate the mechanism of insulin resistance in human skeletal muscle, strips of rectus abdominis muscle from lean (body mass index [BMI] < 25), obese (BMI > 30), and obese non-insulin-dependent diabetes mellitus (NIDDM) (BMI > 30) patients were incubated under basal and insulin-, hypoxia-, and hypoxia + insulin-stimulated conditions. Insulin significantly stimulated 2-deoxyglucose transport approximately twofold in muscle from lean (P < 0.05) patients, but not in muscle from obese or obese NIDDM patients. Furthermore, maximally insulin-stimulated transport rates in muscle from obese and diabetic patients were significantly lower than rates in muscle from lean patients (P < 0.05). Hypoxia significantly stimulated glucose transport in muscle from lean and obese patients. There were no significant differences in hypoxia-stimulated glucose transport rates among lean, obese, and obese NIDDM groups. Hypoxia + insulin significantly stimulated glucose transport in lean, obese, and diabetic muscle. The results of the present study suggest that the glucose transport effector system is intact in diabetic human muscle when stimulated by hypoxia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789635     DOI: 10.2337/diab.44.6.695

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

Review 1.  Metabolic changes through hypoxia in humans and in yeast as a comparable cell model.

Authors:  Nikolaus C Netzer; Michael Breitenbach
Journal:  Sleep Breath       Date:  2010-06-10       Impact factor: 2.816

2.  Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients.

Authors:  Gianni Biolo; Gianfranco Guarnieri; Rocco Barazzoni; Giovanni Panzetta
Journal:  Clin Exp Med       Date:  2010-11-16       Impact factor: 3.984

3.  Fighting obesity: When muscle meets fat.

Authors:  Xin Yang; Pengpeng Bi; Shihuan Kuang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

4.  Intermittent hypoxia maintains glycemia in streptozotocin-induced diabetic rats.

Authors:  Xiaofei Chen; Tong Zhao; Xin Huang; Liying Wu; Kuiwu Wu; Ming Fan; Lingling Zhu
Journal:  Cell Stress Chaperones       Date:  2016-02-22       Impact factor: 3.667

Review 5.  Does sustained weight loss reverse the metabolic syndrome?

Authors:  Annie Ferland; Robert H Eckel
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

6.  Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study.

Authors:  Jacob T Mey; Adithya Hari; Christopher L Axelrod; Ciarán E Fealy; Melissa L Erickson; John P Kirwan; Raed A Dweik; Gustavo A Heresi
Journal:  Eur Respir J       Date:  2020-04-09       Impact factor: 16.671

Review 7.  Therapeutic potential of intermittent hypoxia: a matter of dose.

Authors:  Angela Navarrete-Opazo; Gordon S Mitchell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-17       Impact factor: 3.619

Review 8.  Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity.

Authors:  Aritz Urdampilleta; Pedro González-Muniesa; María P Portillo; J Alfredo Martínez
Journal:  J Physiol Biochem       Date:  2011-11-03       Impact factor: 4.158

Review 9.  Severe obesity: evidence for a deranged metabolic program in skeletal muscle?

Authors:  Joseph A Houmard; Walter J Pories; G Lynis Dohm
Journal:  Exerc Sport Sci Rev       Date:  2012-10       Impact factor: 6.230

10.  Acute altitude-induced hypoxia suppresses plasma glucose and leptin in healthy humans.

Authors:  Karen R Kelly; David L Williamson; Ciarán E Fealy; David A Kriz; Raj K Krishnan; Hazel Huang; Janice Ahn; Joseph L Loomis; John P Kirwan
Journal:  Metabolism       Date:  2009-09-17       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.